Pay in 4 interest-free payments of $6.19 Learn more
Ships within 48 hours · Estimated delivery Sep 28 - Oct 3
PubMed PMID: 25024695
Semaglutide 2.4 mg, a glucagon-like peptide-1 receptor agonist, is a once-weekly injectable pharmacological treatment, indicated in combination with diet and exercise, for reducing body weight in adults with obesity or overweight and at least one ORC [8]
Semaglutide also helps manage blood sugar in people who have type 2 diabetes
Mice lacking Kruppel-like factor (KLF) 10 in CD4 + T cells show decreased TGF-3 secretion, impaired regulatory T-cell (Treg) migration, and develop obesity, insulin resistance, and fatty liver
US$ 22.63
US$ 26.54
US$ 27.45
US$ 27.83
US$ 22.61
US$ 25.18
US$ 27.84
